BR100 Increased By (0.11%)
BR30 Decreased By (-0.26%)
KSE100 Increased By (0.12%)
KSE30 Increased By (0.09%)
AGHA 7.79 Increased By ▲ 0.04 (0.52%)
BECO 5.23 Increased By ▲ 0.04 (0.77%)
BML 57.26 Decreased By ▼ -1.40 (-2.39%)
BOP 34.10 Increased By ▲ 0.41 (1.22%)
CNERGY 9.92 Decreased By ▼ -0.69 (-6.5%)
CSIL 5.35 Increased By ▲ 0.05 (0.94%)
FCCL 54.61 Increased By ▲ 0.87 (1.62%)
FFL 16.70 Increased By ▲ 0.24 (1.46%)
FNEL 1.24 Increased By ▲ 0.02 (1.64%)
KEL 7.42 Increased By ▲ 0.14 (1.92%)
KOSM 5.75 Increased By ▲ 0.11 (1.95%)
LOTCHEM 29.35 Decreased By ▼ -0.30 (-1.01%)
MLCF 94.35 Decreased By ▼ -2.01 (-2.09%)
NBP 202.70 Decreased By ▼ -0.83 (-0.41%)
NCPL 57.00 Increased By ▲ 0.15 (0.26%)
NPL 67.78 Increased By ▲ 0.47 (0.7%)
OGDC 316.40 Decreased By ▼ -1.82 (-0.57%)
PACE 10.64 Increased By ▲ 0.01 (0.09%)
PAEL 43.15 Increased By ▲ 1.38 (3.3%)
PIBTL 16.72 Decreased By ▼ -0.09 (-0.54%)
PPL 220.50 Increased By ▲ 0.33 (0.15%)
PRL 49.05 No Change ▼ 0.00 (0%)
PTC 70.98 Increased By ▲ 0.97 (1.39%)
SSGC 28.17 Decreased By ▼ -0.97 (-3.33%)
TBL 9.90 Increased By ▲ 0.13 (1.33%)
TELE 8.80 Decreased By ▼ -0.02 (-0.23%)
TPL 18.14 Increased By ▲ 0.97 (5.65%)
TPLP 13.40 Increased By ▲ 0.89 (7.11%)
TREET 22.75 Increased By ▲ 0.16 (0.71%)
TRG 60.30 Increased By ▲ 0.08 (0.13%)
By

KARACHI: The Drug Regulatory Authority of Pakistan (DRAP) has registered’ another locally produced ventilator, ‘Innovent’, in Pakistan, sources said Tuesday.

As per details, the Innovent ventilator, manufactured by Essence Industries Karachi, has successfully completed its clinical trials.

DRAP has officially registered the Innovent ventilator and issued a license to Essence Industries for its local production. In addition to meeting domestic demand, the ventilators will also be exported, contributing to the Pakistan’s economy.

The Innovent ventilator has a shelf life of five years and is specifically designed for use by elderly patients, DRAP sources added.

Talking to a private television channel, DRAP CEO Dr. Asim Rauf said the priority of promoting Made in Pakistan medicines and medical equipment.

“Pakistan’s pharmaceutical industry has entered a new era, and the export of locally produced ventilators will generate significant foreign exchange for the country. These live-saving machines will also serve as a symbol of Pakistan’s global recognition,” Dr. Asim Rauf stated. He further highlighted that the success of Made in Pakistan medical devices reflects the country’s growing technological capabilities and commitment to innovation.

Earlier in 2021, the Drug Regulatory Authority of Pakistan (DRAP) registered an indigenously-developed intensive care unit (ICU) ventilator named “i-LIVE”.

The life-support machine was developed by the Pakistan Atomic Energy Commission (PAEC).

Chief Executive Officer of the DRAP Dr. Asim Rauf said that the i-LIVE ventilator was registered for a five-year period under the DRAP Act 2012 after its thorough technical examination.

Comments

Comments are closed for this article.